Dark Blue Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeDark Blue Therapeutics
Dark Blue Therapeutics logo

Dark Blue Therapeutics

0 followers

About Dark Blue Therapeutics

Dark Blue Therapeutics is a biotech company focused on precision oncology, developing next-generation cancer therapies. It collaborates with leading academic experts to identify novel cancer dependencies and applies cutting-edge discovery science to create targeted, transformational medicines for patients with high unmet needs. The company emphasizes a pipeline of precision medicines for molecularly defined patient populations and situates its work within a global oncology research ecosystem.

Recent News

Recent Deals

Key Team Members

Alastair MacKinnon

CEO

Sarah Major

Director Of Medicinal Chemistry

Graham Craggs

Director Of Translational And Mechanistic Biology

Alison Maloney

Head Of Biology

Iain Simpson

Head Of Medicinal Chemistry

Key Facts

HQ Location

Oxford, United Kingdom

Founded

2020

Employees

11 - 50

Status

Private

Website

https://darkbluetx.com